Literature DB >> 26186945

Reduced FoxO3a expression causes low autophagy in idiopathic pulmonary fibrosis fibroblasts on collagen matrices.

Jintaek Im1, Polla Hergert2, Richard Seonghun Nho3.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic and fatal lung disease, and fibroblasts derived from patients with IPF are resistant to type I collagen matrix-induced cell death. The alteration of the PTEN-Akt axis permits IPF fibroblasts to maintain a pathological phenotype on collagen by suppressing autophagy. However, the precise underlying mechanism by which the Akt downstream molecule suppresses autophagic activity remains elusive. FoxO3a is a direct target of Akt and is implicated with the transcriptional activation of autophagy. Therefore, we investigated whether reduced FoxO3a expression causes abnormally low autophagy in IPF fibroblasts on collagen. We found that FoxO3a mRNA and protein levels are low in IPF fibroblasts, which subsequently suppresses the autophagosomal marker LC3B expression on collagen matrix. In contrast, the majority of control fibroblasts showed an increase in FoxO3a and LC3B expression at both the mRNA and protein levels. The luciferase assay confirmed that FoxO3a binds to the promoter region of LC3B and transcriptionally activates LC3B. The overexpression of wild-type FoxO3a increased LC3B mRNA and protein expression in IPF fibroblasts, whereas the dominant negative FoxO3a decreased the LC3B level in control fibroblasts. The inhibition of autophagic activity sensitized control fibroblasts to collagen matrix-induced cell death. In contrast, enhanced viability was found when autophagic function was inhibited in IPF fibroblasts. Our study showed that aberrantly low FoxO3a expression participates in reducing autophagic activity via transcriptional suppression of LC3B in IPF fibroblasts on collagen. This suggests that low autophagic activity by the alteration of FoxO3a may contribute to IPF progression.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  autophagy; cell viability; collagen matrix; forkhead box O3a; idiopathic pulmonary fibrosis fibroblasts; light chain 3B

Mesh:

Substances:

Year:  2015        PMID: 26186945      PMCID: PMC4572418          DOI: 10.1152/ajplung.00079.2015

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  33 in total

1.  FoxO transcription factors promote autophagy in cardiomyocytes.

Authors:  Arunima Sengupta; Jeffery D Molkentin; Katherine E Yutzey
Journal:  J Biol Chem       Date:  2009-08-19       Impact factor: 5.157

2.  TGF-β activation and lung fibrosis.

Authors:  Amanda L Tatler; Gisli Jenkins
Journal:  Proc Am Thorac Soc       Date:  2012-07

3.  Methods in mammalian autophagy research.

Authors:  Noboru Mizushima; Tamotsu Yoshimori; Beth Levine
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

4.  Decreased expression of Beclin-1 and LC3 in human lung cancer.

Authors:  Zi-Feng Jiang; Li-Jie Shao; Wei-Min Wang; Xue-Bo Yan; Rong-Yu Liu
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

5.  Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type i collagen matrix.

Authors:  Richard Seonghun Nho; Polla Hergert; Judith Kahm; Jose Jessurun; Craig Henke
Journal:  Am J Pathol       Date:  2011-09-03       Impact factor: 4.307

Review 6.  The FoxO code.

Authors:  D R Calnan; A Brunet
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

Review 7.  Autophagy and the integrated stress response.

Authors:  Guido Kroemer; Guillermo Mariño; Beth Levine
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

Review 8.  Autophagy in the pathogenesis of disease.

Authors:  Beth Levine; Guido Kroemer
Journal:  Cell       Date:  2008-01-11       Impact factor: 41.582

Review 9.  Autophagy in immunity and inflammation.

Authors:  Beth Levine; Noboru Mizushima; Herbert W Virgin
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

10.  Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis.

Authors:  Hong Xia; Deanna Diebold; Richard Nho; David Perlman; Jill Kleidon; Judy Kahm; Svetlana Avdulov; Mark Peterson; John Nerva; Peter Bitterman; Craig Henke
Journal:  J Exp Med       Date:  2008-06-09       Impact factor: 14.307

View more
  31 in total

Review 1.  Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.

Authors:  Ana L Mora; Marta Bueno; Mauricio Rojas
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 2.  New therapeutics based on emerging concepts in pulmonary fibrosis.

Authors:  Vishwaraj Sontake; Prathibha R Gajjala; Rajesh K Kasam; Satish K Madala
Journal:  Expert Opin Ther Targets       Date:  2018-11-28       Impact factor: 6.902

Review 3.  Differential regulation of autophagy and mitophagy in pulmonary diseases.

Authors:  Saurabh Aggarwal; Praveen Mannam; Jianhua Zhang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-08       Impact factor: 5.464

Review 4.  Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis.

Authors:  David N O'Dwyer; Shanna L Ashley; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

Review 5.  Role of apoptosis and autophagy in tuberculosis.

Authors:  Adam Lam; Rohan Prabhu; Christine M Gross; Lee Ann Riesenberg; Vinodkumar Singh; Saurabh Aggarwal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-11       Impact factor: 5.464

6.  Effects of Polygonum cuspidatum on AMPK-FOXO3α Signaling Pathway in Rat Model of Uric Acid-Induced Renal Damage.

Authors:  Wei-Guo Ma; Jie Wang; Xiang-Wei Bu; Hong-Hong Zhang; Jian-Ping Zhang; Xiao-Xu Zhang; Yu-Xi He; Da-Li Wang; Zheng-Ju Zhang; Feng-Xian Meng
Journal:  Chin J Integr Med       Date:  2017-12-28       Impact factor: 1.978

Review 7.  Matrix remodeling in chronic lung diseases.

Authors:  Bon-Hee Gu; Matthew C Madison; David Corry; Farrah Kheradmand
Journal:  Matrix Biol       Date:  2018-03-17       Impact factor: 11.583

8.  Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis.

Authors:  Meredith L Sosulski; Rafael Gongora; Carol Feghali-Bostwick; Joseph A Lasky; Cecilia G Sanchez
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-05-01       Impact factor: 6.053

9.  "Scar-cinoma": viewing the fibrotic lung mesenchymal cell in the context of cancer biology.

Authors:  Jeffrey C Horowitz; John J Osterholzer; Antonia Marazioti; Georgios T Stathopoulos
Journal:  Eur Respir J       Date:  2016-03-30       Impact factor: 16.671

10.  Autophagy and the unfolded protein response promote profibrotic effects of TGF-β1 in human lung fibroblasts.

Authors:  Saeid Ghavami; Behzad Yeganeh; Amir A Zeki; Shahla Shojaei; Nicholas J Kenyon; Sean Ott; Afshin Samali; John Patterson; Javad Alizadeh; Adel Rezaei Moghadam; Ian M C Dixon; Helmut Unruh; Darryl A Knight; Martin Post; Thomas Klonisch; Andrew J Halayko
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-26       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.